Skip to main content
CRISM Therapeutics Corporation (AIM:CRTX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
12.00
-1.00 (-7.69%)
Apr 29, 2026, 2:49 PM GMT

CRISM Therapeutics Cash Flow Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
 Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-1.52-0.61-0.2-2.5-0.89-1.95
Upgrade
Depreciation & Amortization
0.020.020.02-0.20
Upgrade
Other Operating Activities
0.05-0.290.07-0.4-0.670.34
Upgrade
Change in Accounts Receivable
0.02-0.37----
Upgrade
Change in Accounts Payable
0.110.310.02---
Upgrade
Operating Cash Flow
-1.33-0.93-0.1-2.92-1.35-1.61
Upgrade
Capital Expenditures
-----0.31-0.41
Upgrade
Cash Acquisitions
-2.36----
Upgrade
Divestitures
----4.53-
Upgrade
Sale (Purchase) of Intangibles
-0.09-0.03-0.01---
Upgrade
Other Investing Activities
----0.420.240.03
Upgrade
Investing Cash Flow
-0.092.33-0.01-0.424.46-3.79
Upgrade
Short-Term Debt Issued
-----0.44
Upgrade
Total Debt Issued
-----0.44
Upgrade
Short-Term Debt Repaid
------0.53
Upgrade
Total Debt Repaid
------0.53
Upgrade
Net Debt Issued (Repaid)
------0.08
Upgrade
Issuance of Common Stock
-0.1-0.29-7.33
Upgrade
Common Dividends Paid
-0.05-0.05----
Upgrade
Other Financing Activities
-0.12-0.12-0.52--
Upgrade
Financing Cash Flow
-0.17-0.07-0.8-7.25
Upgrade
Foreign Exchange Rate Adjustments
0.08-0.05---0.23-0.09
Upgrade
Net Cash Flow
-1.511.28-0.11-2.542.871.75
Upgrade
Free Cash Flow
-1.33-0.93-0.1-2.92-1.67-2.02
Upgrade
Free Cash Flow Margin
-5336.00%-3732.00%-217.78%---
Upgrade
Free Cash Flow Per Share
-0.03-0.03-6.13-0.34-0.19-0.30
Upgrade
Cash Income Tax Paid
---0.04---
Upgrade
Levered Free Cash Flow
-1.69-0.6519-1.91-18.57-1.42
Upgrade
Unlevered Free Cash Flow
-1.69-0.6519.02-1.91-18.57-1.42
Upgrade
Change in Working Capital
0.13-0.060.02---
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.